Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis

Term Efficacy ◽

AB0398 COMPARATIVE SAFETY OF ABATACEPT AND OTHER NON-TUMOR NECROSIS FACTOR INHIBITORS IN RHEUMATOID ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS

10.1136/annrheumdis-2019-eular.4357 ◽

2019 ◽

Cited By ~ 1

Author(s):

Damemarie Paul ◽

Benjamin Taylor ◽

Yuting Kuang ◽

Mir Sohail Fazeli

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Literature Review ◽

Systematic Literature Review ◽

Tumor Necrosis ◽

Meta Analysis ◽

Comparative Safety ◽

Systematic Literature Review and Meta-analysis of Tumor Necrosis Factor–Alpha Experienced Rheumatoid Arthritis

Clinical Therapeutics ◽

10.1016/j.clinthera.2017.06.013 ◽

2017 ◽

Vol 39 (8) ◽

pp. 1680-1694.e2 ◽

Cited By ~ 6

Author(s):

Alvin F. Wells ◽

Jeffrey R. Curtis ◽

Keith A. Betts ◽

Kevin Douglas ◽

Ella Xiaoyan Du ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Literature Review ◽

Tumor Necrosis Factor Alpha ◽

Systematic Literature Review ◽

Tumor Necrosis ◽

Meta Analysis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.13248 ◽

2018 ◽

Vol 21 (3) ◽

pp. 673-687 ◽

Cited By ~ 3

Author(s):

Taio Naniwa ◽

Shiho Iwagaitsu ◽

Mikiko Kajiura

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Efficacy And Safety ◽

Term Efficacy ◽

Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.11.004 ◽

2016 ◽

Vol 38 (12) ◽

pp. 2628-2641.e5 ◽

Cited By ~ 16

Author(s):

Maria-Cecilia Vieira ◽

Samuel H. Zwillich ◽

Jeroen P. Jansen ◽

Brielan Smiechowski ◽

Dean Spurden ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Inadequate Response ◽

The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database

Rheumatology International ◽

10.1007/s00296-014-3045-8 ◽

2014 ◽

Vol 34 (12) ◽

pp. 1729-1736 ◽

Cited By ~ 8

Author(s):

Ryoko Sakai ◽

◽

Soo-Kyung Cho ◽

Toshihiro Nanki ◽

Ryuji Koike ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Serious Infection ◽

Necrosis Factor ◽

Over Time

FRI0214 Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study

10.1136/annrheumdis-2017-eular.6486 ◽

2017 ◽

Author(s):

Y Tanaka ◽

D Aletaha ◽

P Agarwal ◽

R Kurrasch ◽

PP Tak ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Efficacy And Safety ◽

Phase 3 ◽

Term Efficacy ◽

Factor Therapy ◽

Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.12822 ◽

2015 ◽

Vol 19 (11) ◽

pp. 1103-1111 ◽

Cited By ~ 15

Author(s):

Young Ho Lee ◽

Sang-Cheol Bae

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

FRI0256 Risk of Relapse after Discontinuing Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients with Low Disease Activity: A Systematic Review and Meta-Analysis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.5498 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 476.1-476

Author(s):

N. Filippi ◽

J. Morel ◽

B. Combe ◽

C. Lukas

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Tumor Necrosis Factor ◽

Disease Activity ◽

Tumor Necrosis ◽

Meta Analysis ◽

Low Disease Activity ◽

Necrosis Factor ◽

Risk Of Relapse

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Arthritis Research & Therapy ◽

10.1186/s13075-015-0583-8 ◽

2015 ◽

Vol 17 (1) ◽

Cited By ~ 33

Author(s):

Ryoko Sakai ◽

◽

Soo-Kyung Cho ◽

Toshihiro Nanki ◽

Kaori Watanabe ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-Analysis of Randomized Trials

Arthritis Care & Research ◽

10.1002/acr.22618 ◽

2015 ◽

Vol 67 (11) ◽

pp. 1487-1495 ◽

Cited By ~ 12

Author(s):

Niels Graudal ◽

Thorbjørn Hubeck-Graudal ◽

Mikkel Faurschou ◽

Bo Baslund ◽

Gesche Jürgens

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Combination Therapy ◽

Tumor Necrosis ◽

Randomized Trials ◽

Meta Analysis ◽